Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 27 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2018Effects of the bitter taste receptor agonist, denatonium benzoate, on postprandial glycaemia, gastric emptying and energy intake in type 2 diabetesXie, C.; Wang, X.; Bound, M.; Grivell, J.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C.; Wu, T.; 54th Annual Meeting of the European Association for the Study of Diabetes (EASD 2018) (01 Oct 2018 - 05 Oct 2018 : Berlin, GERMANY)
2013Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humansWu, T.; Bound, M.; Standfield, S.; Gedulin, B.; Jones, K.; Horowitz, M.; Rayner, C.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2016Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2015Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy malesWu, T.; Thazhath, S.; Marathe, C.; Bound, M.; Jones, K.; Horowitz, M.; Rayner, C.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humansWu, T.; Bound, M.; Standfield, S.; Bellon, M.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2015Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?Wu, T.; Trahair, L.; Bound, M.; Deacon, C.; Horowitz, M.; Rayner, C.; Jones, K.
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.